- increased circulating alanine transaminase level / IMPC
C57BL/6N-Atm1Brd Il23rtm2a(EUCOMM)Wtsi/WtsiFlmg
Status | Available to order |
EMMA ID | EM:08477 |
International strain name | C57BL/6N-Atm1Brd Il23rtm2a(EUCOMM)Wtsi/WtsiFlmg |
Alternative name | EPD0812_2_G05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Il23rtm2a(EUCOMM)Wtsi |
Gene/Transgene symbol | Il23r |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0812_2_G05. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | B.S.R.C. Alexander Fleming, Vari, Greece |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating alanine transaminase level / IMPC
MGI phenotypes (gene matching)
- no phenotypic analysis / MGI
- abnormal response/metabolism to endogenous compounds / MGI
- decreased susceptibility to experimental autoimmune encephalomyelitis / MGI
- immune system phenotype / MGI
- abnormal CD4-positive, alpha-beta T cell physiology / MGI
- abnormal CD4-positive T cell differentiation / MGI
- decreased susceptibility to induced colitis / MGI
- abnormal circulating interleukin level / MGI
- increased circulating interleukin-17 level / MGI
- decreased interleukin-9 secretion / MGI
- decreased physiological sensitivity to xenobiotic / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).